Literature DB >> 12214252

Roles of BRCA1 in centrosome duplication.

Chu-Xia Deng1.   

Abstract

Centrosome duplication is under precise control and occurs only once in a normal mammalian cell cycle. Disruption of this process causes centrosome amplification, unequal segregation of chromosomes and, ultimately, tumorigenesis. Recent studies indicate that breast cancer suppressor gene 1 (BRCA1) plays an important role in regulating centrosome duplication. BRCA1 is located in the centrosome and binds to gamma-tubulin. It interacts with a variety of proteins that regulate centrosome duplication, including BRCA2, CDK2-Cyclin A, CDK2-Cyclin E, Gadd45, p21, p53 and Rb. Furthermore, targeted disruption of murine BRCA1 results in centrosome amplification, suggesting that BRCA1 serves as a negative regulator for centrosome duplication. This review will examine these data and discuss possible relationships between BRCA1 and its interacting proteins in centrosome duplication.

Entities:  

Mesh:

Year:  2002        PMID: 12214252     DOI: 10.1038/sj.onc.1205713

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria.

Authors:  Elisabeth D Coene; Michael S Hollinshead; Anouk A T Waeytens; Vera R J Schelfhout; Willy P Eechaute; Michael K Shaw; Patrick M V Van Oostveldt; David J Vaux
Journal:  Mol Biol Cell       Date:  2004-12-09       Impact factor: 4.138

5.  Identification and functional characterization of a PP1-binding site in BRCA1.

Authors:  Lih-Ching Hsu
Journal:  Biochem Biophys Res Commun       Date:  2007-06-26       Impact factor: 3.575

6.  BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression.

Authors:  Shunqian Jin; Hua Gao; Lucia Mazzacurati; Yang Wang; Wenhong Fan; Qiang Chen; Wei Yu; Mingrong Wang; Xueliang Zhu; Chuanmao Zhang; Qimin Zhan
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

7.  Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Cuiling Li; Xiaoling Xu; L Julie Huber; Lewis A Chodosh; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

Authors:  Edward H Cho; Rebecca A Whipple; Michael A Matrone; Eric M Balzer; Stuart S Martin
Journal:  Cancer Biol Ther       Date:  2010-01-28       Impact factor: 4.742

9.  Association of loss of BRCA1 expression with centrosome aberration in human breast cancer.

Authors:  Atsushi Shimomura; Yasuo Miyoshi; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-24       Impact factor: 4.553

10.  Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.

Authors:  Rui-Hong Wang; Yin Zheng; Hyun-Seok Kim; Xiaoling Xu; Liu Cao; Tyler Luhasen; Mi-Hye Lee; Cuiying Xiao; Athanassios Vassilopoulos; Weiping Chen; Kevin Gardner; Yan-Gao Man; Mien-Chie Hung; Toren Finkel; Chu-Xia Deng
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.